Screener
Aura Biosciences, Inc. AURA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Right-of-use assets - operating lease | 15,416 | 15,828 |
| Other long-term assets | 517 | 471 |
| Property and equipment, net | 2,472 | 2,624 |
| Total Assets | $137,677 | $169,430 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | 2,573 | 1,549 |
| Short-term operating lease liability | 3,267 | 3,243 |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s total assets?
- Aura Biosciences, Inc. (AURA) reported total assets of $137.68M in Q1 2026.
- How has Aura Biosciences, Inc.'s total assets changed year-over-year?
- Aura Biosciences, Inc.'s total assets decreased by 11.4% year-over-year, from $155.4M to $137.68M.
- What is the long-term trend for Aura Biosciences, Inc.'s total assets?
- Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s total assets has grown at a 50.3% compound annual growth rate (CAGR), from $22.1M to $169.43M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Aura Biosciences, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude